Credit Suisse Ag Harvard Bioscience Inc Transaction History

Credit Suisse Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.12 - $2.86 $48,972 - $66,066	23,100 New	23,100 $63,000
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.42 $68 - $134	21 New	21 $0
Q1 2021 May 14, 2021	SELL	$3.91 - $6.99 $42,673 - $76,288	-10,914 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.0 - $4.5 $32,742 - $49,113	10,914 New	10,914 $47,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.